Adverum Biotechnologies Correlations
ADVM Stock | USD 6.45 0.29 4.71% |
The current 90-days correlation between Adverum Biotechnologies and Uniqure NV is 0.44 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Adverum Biotechnologies Correlation With Market
Weak diversification
The correlation between Adverum Biotechnologies and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adverum Biotechnologies and DJI in the same portfolio, assuming nothing else is changed.
Adverum |
Moving together with Adverum Stock
Moving against Adverum Stock
0.32 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.48 | ANTX | AN2 Therapeutics | PairCorr |
0.33 | ACIU | AC Immune | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Adverum Stock performing well and Adverum Biotechnologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adverum Biotechnologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
QURE | 4.01 | (0.30) | 0.02 | 0.05 | 4.54 | 11.07 | 36.04 | |||
RCKT | 2.88 | (0.59) | 0.00 | (0.21) | 0.00 | 6.59 | 21.07 | |||
RYTM | 2.36 | 0.26 | 0.12 | 0.25 | 2.41 | 6.15 | 17.61 | |||
SLDB | 3.55 | (0.91) | 0.00 | (0.24) | 0.00 | 7.44 | 24.49 | |||
MGTX | 2.74 | 0.60 | 0.22 | 0.44 | 2.52 | 6.75 | 21.07 | |||
AVTE | 2.45 | 0.45 | 0.18 | 0.57 | 2.04 | 5.58 | 19.11 | |||
ADAG | 4.44 | (0.25) | 0.00 | (0.78) | 0.00 | 8.13 | 37.93 | |||
ACRV | 2.87 | (0.43) | 0.00 | (0.13) | 0.00 | 7.66 | 22.84 | |||
RZLT | 2.78 | (0.03) | 0.01 | 0.09 | 3.11 | 6.80 | 30.01 | |||
ANTX | 1.86 | 0.19 | 0.06 | 0.34 | 1.86 | 3.73 | 28.03 |
Adverum Biotechnologies Corporate Management
Jim Wang | Chief Officer | Profile | |
Andrew Ramelmeier | Chief Officer | Profile | |
Romuald Corbau | Chief Officer | Profile | |
Kalliopi MD | Senior Development | Profile | |
Michael Steel | Senior Quality | Profile | |
Rabia MD | Chief Officer | Profile |